DURECT Corporation

Durect Corp is a biopharmaceutical company. It is engaged in the research, development and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and drug delivery programs. The company’s pipeline products consist of DUR-928, RBP-7000, Remoxy, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan and other countries, of which key revenue is derived from Europe and the US.